Antischistosomal activity of imidazolidine-2,4-dione derivatives
Schistosomiasis is a neglected tropical disease with limited treatment options and growing concerns over praziquantel resistance. We evaluated a series of 12 synthetic compounds for antiparasitic activity against <i>Schistosoma mansoni</i> adult worms <i>in vitro</i>. Isoindole-1,3-dione derivatives were inactive, whereas four imidazolidine-2,4-dione derivatives displayed selective antischistosomal activity with low cytotoxicity in mammalian cells. These findings highlight imidazolidine-2,4-dione as a promising scaffold for the development of new therapeutic agents against schistosomiasis.
Authors
- Anna Jaromin (ORCID: https://orcid.org/0000-0002-7921-8007)
- Agnieszka Zagórska (ORCID: https://orcid.org/0000-0003-2510-7237)
- Anna Czopek (ORCID: https://orcid.org/0000-0002-1448-9826)
- Thainá R. Teixeira (ORCID: https://orcid.org/0009-0001-4787-5934)
- Josué de Moraes
Institutions
- Jagiellonian University (PL)
- Drugs for Neglected Diseases Initiative (CH)
- University of Liège (BE)
- Guarulhos University (BR)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1128/aac.01748-25
- Primary Topic
- Parasites and Host Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00